Use of anti-EGFR agents among elderly patients with metastatic colorectal cancer (mCRC).

被引：0
|
作者：
D'Silva, Ashley James
Dotan, Efrat
Kloth, Dwight D.
Beck, Andrew
Cohen, Steven J.
Denlinger, Crystal Shereen
机构：
[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
[2] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
657
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)
    S. Abdelwahab
    A. Azmy
    H. Abdel-aziz
    H. Salim
    A. Mahmoud
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1487 - 1492
  • [2] Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)
    Abdelwahab, S.
    Azmy, A.
    Abdel-aziz, H.
    Salim, H.
    Mahmoud, A.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (09) : 1487 - 1492
  • [3] Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
    Chong, Li Chia
    Hardingham, Jennifer E.
    Townsend, Amanda R.
    Piantadosi, Cynthia
    Rico, Gonzalo Tapia
    Karapetis, Chris
    Padbury, Rob
    Maddern, Guy
    Roy, Amitesh
    Price, Timothy J.
    TARGETED ONCOLOGY, 2020, 15 (06) : 751 - 757
  • [4] Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry
    Li Chia Chong
    Jennifer E. Hardingham
    Amanda R. Townsend
    Cynthia Piantadosi
    Gonzalo Tapia Rico
    Chris Karapetis
    Rob Padbury
    Guy Maddern
    Amitesh Roy
    Timothy J. Price
    Targeted Oncology, 2020, 15 : 751 - 757
  • [5] Use of palliative chemotherapy and targeted agents in elderly patients with metastatic colorectal cancer (mCRC).
    Chan, Matthew
    Renouf, Daniel John
    Speers, Caroline
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] USE OF PALLIATIVE CHEMOTHERAPY AND TARGETED AGENTS IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)
    Cheung, W. Y.
    Renouf, D.
    Lim, H.
    Kennecke, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 215 - 215
  • [7] Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis
    Schulz, Martin S.
    Wolf, Sebastian
    Struck, Vera
    Thomas, Niklas
    Husman, Gabriele
    Zeuzem, Stefan
    Koch, Christine
    Trojan, Joerg
    Schnitzbauer, Andreas Anton
    Bechstein, Wolf Otto
    Waidmann, Oliver
    CANCERS, 2022, 14 (07)
  • [8] A method to assess KRAS/BRAF genotype in patients with metastatic colorectal cancer (mCRC) elligible for anti-EGFR therapies
    Lamy, A.
    Labourier, E.
    Prigneau, O.
    Di Fiore, F.
    Sesbouea, R.
    Sabourin, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] Consensus recommendations for the use of anti-EGFR therapies in metastatic colorectal cancer
    Cripps, C.
    Gill, S.
    Ahmed, S.
    Colwell, B.
    Dowden, S.
    Kennecke, H.
    Maroun, J.
    Samson, B.
    Thirlwell, M.
    Wong, R.
    CURRENT ONCOLOGY, 2010, 17 (06) : 272 - 278
  • [10] ANTI-EGFR ANTIBODY RECHALLENGE IN CHEMOREFRACTORY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Kajitani, Tatsuhiro
    Makiyama, Akitaka
    Arita, Shuji
    Kumagai, Hozumi
    Oda, Hisanobu
    Shirakawa, Tsuyoshi
    Esaki, Taito
    ANNALS OF ONCOLOGY, 2014, 25
12345